High shear stress marks: the vulnerable target with von Willebrand factor for platelet deployment -letter-.
Gilutz
H
H
Cardiology Department, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel. gilutz@bgumail.bgu.ac.il.
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D016718:Arachidonic Acid / Q000378:metabolism; D001158:Arteries / Q000293:injuries / Q000378:metabolism / Q000473:pathology; D001792:Blood Platelets / Q000378:metabolism*; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D017434:Protein Structure, Tertiary; D013314:Stress, Mechanical; D014841:von Willebrand Factor / Q000737:chemistry / Q000378:metabolism*
D014841:von Willebrand Factor; C061163:11-glutathionylhepoxilin A3; D016718:Arachidonic Acid; D009569:Nitric Oxide; D015126:8,11,14-Eicosatrienoic Acid